Regeneron's Yancopoulos on Hearing Loss Gene Therapy, Weight Loss Drugs

Regeneron Chief Scientific Officer George Yancopoulos joins Bloomberg's Katie Greifeld at the annual JP Morgan healthcare conference in San Francisco to talk about the FDA's response to their hearing loss gene therapy as well as their plans to roll out weight loss drugs. (Source: Bloomberg)...

Redirecting to full article...